MHC-class I expression on prostate carcinoma and modulation by IFN-γ

Japanese Journal of Urology

Volumn 93, Issue 4, 2002, Pages 532-538

  Naoe, Michio ^a   Marumoto, Yoshiko ^a   Aoki, Keiichiro ^a   Fukagai, Takashi ^a   Ogawa, Yoshio ^a   Ishizaki, Ryoutaro ^a   Nakagami, Yoshizo ^a   Yoshida, Hideki ^a   Ballo, Michel ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CTL; MHC class I; Prostate carcinoma

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; MALE; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0036271337     PISSN: 00215287     EISSN: None     Source Type: Journal    
DOI: 10.5980/jpnjurol1989.93.532     Document Type: Article

References (20)

1. The role of recognition of tumor antigens by non-cytolytic-type of antitumor T cell: Role of antigen-presenting cells and their surface class I and class II H-2 molecules
2. Selective changes in expression of HLA class I polimorphic determinants in human solid tumors
3. Loss of MHC class-I expression in cervical carcinomas
4. Engineering dendritic cell grafts for clinical trials in cellular immunotherapy of cancer: Example of chronic myelogenous leukemia
5. Dendritic cell-based vaccines in patients with hematological malignancies
6. Clinical approaches to vaccination in oncology
7. Expression of immunoglobulin superfamily cell adhesion molecules on murine embryonic stem cells
8. Epithelium specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker
9. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
10. Dendritic cell-based immunotherapy of prostate cancer: Immune moritoring of phase II clinical trial
11. Molecular characterization of defective antigen processing in human prostate cancer
12. Transforming growth factor-β: An important mediator of immunoregulation
13. Tumor associated leucocytes: Friends or foes in breast carcinoma
14. Differential expression of HLA class I and class II antigens in primary and metastatic melanomas
15. Loss of Hla-A, B, C and de novo expression of HLA-D in colorectal cancer
16. MHC class I and class II expression in prostate carcinoma and modulation by interferon-alpha and gamma
17. Stern: Loss of HLA Class I expression in prostate cancer: Implications for Immunology
18. HLA class I and class II expression of plumonaly adenocarcinoma cells and the influence of interferon gamma
19. Vaccination of melanoma patients with peptide or tumor lysate-pulsed dendritic cells
20. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids